Corporate Profile - Mediscience Technology Corporation is successfully engaged in the design and development of diagnostic medical devices that detect cancer using light induced native tissue fluorescence spectroscopy to distinguish between malignant and normal or benign tissue.
Corporate Headquarters
1235 Folkstone Way
Cherry Hill, New Jersey 08034
Telephone: 856-428-7952
Fax: 215-763-2908
Corporate Officers
Peter Katevatis Esq., Chairman and CEO
Key Personnel
Peter Katevatis Esq., Chairman and CEO
Peter Katevatis has served as Chairman of the Board of Directors since 1993. He is a practicing attorney admitted to the Pennsylvania, New York, New Jersey and the Washington DC bar associations.
Mr. Katevatis served as fiduciary trustee of the New Jersey Police and Firemans Fund and as a member of the New Jersey State Investment Council from 1990 to 1993. In that capacity, he participates in the fiduciary investment and oversight of all New Jersey state pension funds totaling approximately 50 billion dollars.
He serves as a judicial arbitrator for the American Arbitration Association and the National Association of Securities Dealers (NASD). Mr. Katevatis is also a long-time member of the National District Attorney's Association.
Frederick Naftolin, MD, PhD
Chairman of Scientific Advisory Board (Mediscience Technology)
Frederick Naftolin, MD, PhD is a Professor for the Department of Obstetrics and Gynecology at New York University School of Medicine. He was the former Chairman Emeritus of the Department of Obstetrics, Gynecology and Reproductive Sciences, Professor of Obstetrics, Gynecology and Reproductive Sciences and of Molecular, Cellular and Developmental Biology, for Yale University.
Dr. Frederick Naftolin obtained his medical degree from University of California, School of Medicine, San Francisco and his doctoral degree from Oxford University. In addition to his considerable clinical experience, Dr. Naftolin has long been an NIH-funded researcher in the areas of reproductive endocrinology and oncology. His work is on the cell- and molecular biology that surround these areas. Dr. Naftolin has been a Guggenheim Scholar, an NIH Fogarty Fellow (X2), and a Berlex International Scholar. Under the aegis of these awards, he has performed research and teaching as a Visiting/Special Professor at the University of Geneva, the Complutensa University and Instituto Cajal (Madrid) and the Weizmann Institute of Technology. Dr. Naftolin is the author of more than 600 original publications and reviews, has edited 12 books and is an editor/associate editor of three journals. He has been honored by the Arnaldo Bruno Prize of the Italian Academy (Lincei) in 2002 and the President's Distinguished Scientist Award of the Society for Gynecological Investigation in 2003. Dr. Naftolin is currently on the Executive Board of the International Menopause Society and the Society for Experimental Biology and Medicine.
